Jim Simons
TXG icon

Jim Simons’s 10x Genomics TXG Stock Holding History

Jim Simons’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.4M Sell
1,008,739
-541,800
-35% -$10.8M 0.03% 618
2025
Q4 		$25.3M Buy
1,550,539
+505,618
+48% +$7.64M 0.04% 501
2025
Q3 		$12.2M Sell
1,044,921
-427,334
-29% -$5.57M 0.02% 991
2025
Q2 		$17M Buy
1,472,255
+782,700
+114% +$7.13M 0.02% 783
2025
Q1 		$6.02M Buy
689,555
+302,600
+78% +$3.81M 0.01% 1316
2024
Q4 		$5.56M Buy
+386,955
New +$6.11M 0.01% 1379
2024
Q3 		– Sell
-210,200
Closed -$4.09M – 3901
2024
Q2 		$4.09M Buy
210,200
+157,800
+301% +$4.13M 0.01% 1440
2024
Q1 		$1.97M Buy
+52,400
New +$2.3M ﹤0.01% 2041
2022
Q2 		– Sell
-57,800
Closed -$4.4M – 4582
2022
Q1 		$4.4M Buy
57,800
+40,000
+225% +$3.5M 0.01% 1692
2021
Q4 		$2.65M Sell
17,800
-74,616
-81% -$11.4M ﹤0.01% 1934
2021
Q3 		$13.5M Buy
+92,416
New +$15.9M 0.02% 865
2021
Q1 		– Sell
-162,700
Closed -$23M – 3715
2020
Q4 		$23M Sell
162,700
-133,400
-45% -$19.4M 0.03% 687
2020
Q3 		$36.9M Buy
296,100
+6,464
+2% +$679K 0.04% 474
2020
Q2 		$25.9M Buy
289,636
+279,100
+2,649% +$21.7M 0.02% 684
2020
Q1 		$657K Buy
+10,536
New +$822K ﹤0.01% 2636

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jim Simons's TXG Position: Q1 2026 in Review

Jim Simons reduced its 10x Genomics (TXG) stake by 35% in Q1 2026, selling an estimated $10.8M and leaving 1,008,739 shares worth $21.4M. The position accounts for 0.03% of the portfolio, ranked #618.

Jim Simons first reported a position in TXG in Q1 2020 and has held it in 15 quarters since. The position peaked at $36.9M in Q3 2020. 330 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Jim Simons held 1,008,739 shares of 10x Genomics worth $21.4M as of Q1 2026.
  • Jim Simons sold 541,800 10x Genomics shares in Q1 2026, an estimated $10.8M.
  • 10x Genomics made up 0.03% of Jim Simons's portfolio in Q1 2026, its #618 holding.
  • Jim Simons first reported a position in 10x Genomics in Q1 2020 and has held it in 15 quarters since.
  • Jim Simons's 10x Genomics position peaked at $36.9M in Q3 2020.
  • 330 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.